These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 20609382)
1. Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich Ascites tumor bearing mice. Mondal N; Halder KK; Kamila MM; Debnath MC; Pal TK; Ghosal SK; Sarkar BR; Ganguly S Int J Pharm; 2010 Sep; 397(1-2):194-200. PubMed ID: 20609382 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
4. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies. Halder KK; Mandal B; Debnath MC; Bera H; Ghosh LK; Gupta BK J Drug Target; 2008 May; 16(4):311-20. PubMed ID: 18446610 [TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. Yin Y; Chen D; Qiao M; Lu Z; Hu H J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180 [TBL] [Abstract][Full Text] [Related]
6. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Joshi SA; Chavhan SS; Sawant KK Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model. Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913 [TBL] [Abstract][Full Text] [Related]
8. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
9. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655 [TBL] [Abstract][Full Text] [Related]
10. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines. Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865 [TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation. Yang A; Yang L; Liu W; Li Z; Xu H; Yang X Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246 [TBL] [Abstract][Full Text] [Related]
14. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies. Lalani J; Rathi M; Lalan M; Misra A Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442 [TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy. Alemrayat B; Elhissi A; Younes HM Pharm Dev Technol; 2019 Feb; 24(2):235-242. PubMed ID: 29561210 [TBL] [Abstract][Full Text] [Related]
18. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres. Stevanović M; Maksin T; Petković J; Filipic M; Uskoković D Nanotechnology; 2009 Aug; 20(33):335102. PubMed ID: 19636100 [TBL] [Abstract][Full Text] [Related]
19. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice. Harivardhan Reddy L; Sharma RK; Chuttani K; Mishra AK; Murthy RS J Control Release; 2005 Jul; 105(3):185-98. PubMed ID: 15921775 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]